MELBOURNE, AUSTRALIA / ACCESSWIRE / April 8, 2015 / Propanc Health Group Corporation (PINKSHEETS:PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company will be featured in the NY Times Sunday Magazine, under Health Essentials: Cancer Prevention & Treatment, April 19th.
The feature is expected to cover the inside story on the Company so far, developments and challenges, and plans to commercialize their technology, from the perspective of the Company’s Co-Founder and Chief Executive Officer, James Nathanielsz.
“We are grateful for the opportunity to share our story through such a reputable firm as the New York Times,” said James Nathanielsz. “Our focus is to share our personal experiences and beliefs about where the Company is heading and what we want to achieve in the fight against cancer.”
Go PPCH!!
News 
Market Data 
Discover 
AI
